← Open Payments lookup

HEATHER FINLAYSON: Open Payments

NPI 1952480873 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$72,106 in 226 payments from 19 companies in 2025. Trend: 2023 $28,713 · 2024 $41,106 · 2025 $72,106

Speaker / faculty: $45,470Travel & lodging: $13,017Consulting: $6,810Food & beverage: $6,720Education: $89
CompanyPaymentsAmount
Janssen Biotech, Inc.40$20,062
UCB, Inc.38$14,595
GENZYME CORPORATION31$12,744
AstraZeneca Pharmaceuticals LP40$11,464
GlaxoSmithKline, LLC.15$7,010
E.R. Squibb & Sons, L.L.C.7$1,387
Eli Lilly and Company1$1,200
Boehringer Ingelheim Pharmaceuticals, Inc.2$1,153
Amgen Inc.17$731
Alexion Pharmaceuticals, Inc.3$549

Products named: TREMFYA, Bimzelx, KEVZARA, SAPHNELO, BENLYSTA, TALTZ, STRENSIQ, KRYSTEXXA.

Industry payments across CO — which companies pay providers there.